Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects (Q38049302)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 October 2012

Language	Label	Description	Also known as
English	Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects	scientific article published on 03 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

Adrian L. Lopresti

object named as

Adrian L Lopresti

1

0 references

object named as

Sean D Hood

2

0 references

author name string

Peter D Drummond

3

1 reference

Europe PubMed Central

27 August 2017

language of work or name

0 references

publication date

3 October 2012

1 reference

Europe PubMed Central

27 August 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

27 August 2017

26

1 reference

Europe PubMed Central

27 August 2017

12

1 reference

Europe PubMed Central

27 August 2017

1512-1524

1 reference

Europe PubMed Central

27 August 2017

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antioxidant and radical scavenging properties of curcumin

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Nitric oxide synthases: structure, function and inhibition

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Bioavailability of curcumin: problems and promises

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenines and the respiratory parameters on rat heart mitochondria

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Adaptogenic potential of curcumin in experimental chronic stress and chronic unpredictable stress-induced memory deficits and alterations in functional homeostasis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The role of serotonin receptor subtypes in treating depression: a review of animal studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Inflammation-associated depression: from serotonin to kynurenine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Nitric oxide and major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A meta-analysis of cytokines in major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A neurotrophic model for stress-related mood disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Effects of cytokines and infections on brain neurochemistry

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Neuroplastic changes in depression: a role for the immune system

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Neuroprotection through stimulation of mitochondrial antioxidant protein expression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Discovery of curcumin, a component of golden spice, and its miraculous biological activities

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin inhibits the increase of glutamate, hydroxyl radicals and PGE2 in the hypothalamus and reduces fever during LPS-induced systemic inflammation in rabbits

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Effects of glutamine and curcumin on bacterial translocation in jaundiced rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Low nNOS protein in the locus coeruleus in major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenines, neurodegeneration and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Major depression in adolescent children consecutively diagnosed with mitochondrial disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Potentials of curcumin as an antidepressant.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

An overview of curcumin in neurological disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antidepressant activity of curcumin: involvement of serotonin and dopamine system

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Increased plasma nitric oxide metabolites in suicide attempters.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A curcumin derivative, 2,6-bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) attenuates prostaglandin E2 synthesis via selective suppression of cyclooxygenase-2 in IFN-γ/LPS-stimulated macrophages.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Mitochondria: more than just a powerhouse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Glutamate: its role in learning, memory, and the aging brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Lower serum vitamin E concentrations in major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

N-acetylcysteine for major depressive episodes in bipolar disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Neurobiology of depression: an integrated view of key findings

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The cellular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Interaction between BDNF and serotonin: role in mood disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

New insights into BDNF function in depression and anxiety

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Ketamine for treatment-resistant unipolar depression: current evidence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Tryptophan hydroxylase as novel target for the treatment of depressive disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antioxidant and anti-inflammatory properties of curcumin

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin Inhibits the proteinase-activated receptor-2-triggered prostaglandin E2 production by suppressing cyclooxygenase-2 upregulation and Akt-dependent activation of nuclear factor-κB in human lung epithelial cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

COX-2 inhibition in schizophrenia and major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenines: from the perspective of major psychiatric disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Th1, Th2, and Th3 cytokine alterations in major depression.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Adrenal gland enlargement in major depression. A computed tomographic study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Low plasma vitamin E levels in major depression: diet or disease?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antioxidant enzyme activities and oxidative stress in affective disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The HPA axis in major depression: classical theories and new developments

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Forced swimming test in mice: a review of antidepressant activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Mitochondrial dysfunction and molecular pathways of disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Depression and cardiovascular disease: role of nitric oxide

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Is depression an inflammatory disorder?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Cytokines sing the blues: inflammation and the pathogenesis of depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Mitochondrial involvement in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The olfactory bulbectomised rat as a model of depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Immunomodulatory and therapeutic activity of curcumin

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The role of zinc in neurodegenerative inflammatory pathways in depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcuminoid analogs inhibit nitric oxide production from LPS-activated microglial cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The STAR*D Project results: a comprehensive review of findings.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

The effects of curcumin on depressive-like behaviors in mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin prevents corticosterone-induced neurotoxicity and abnormalities of neuroplasticity via 5-HT receptor pathway.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Endotoxin produces a depressive-like episode in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Glucocorticoids, cytokines and brain abnormalities in depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

1 reference

https://api.crossref.org/works/10.1177%2F0269881112458732

21 January 2018

Identifiers

10.1177/0269881112458732

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38049302&oldid=1738664530"